Lisa Miller | Senior Director-IR |
Rick Hawkins | CEO and Chairman |
John McKew | President and Chief Scientific Officer |
David Karpf | Chief Medical Officer |
Lori Lawley | CFO and Corporate Controller |
Charles Duncan | Cantor Fitzgerald |
Ed White | H.C. Wainwright |
Catherine Novack | Jones Trading |
Good afternoon, ladies and gentlemen, and welcome to Lumos Pharma's Second Quarter Results Conference Call. Currently, all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time.
As a reminder, this conference call is being recorded. I will now turn the call over to Lisa Miller, Senior Director of Investor Relations.